PAFSC Second Committee Backs Approval of Celgene’s Pomalidomide

February 27, 2015
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Second Committee on Drugs, an advisory organ to the health minister, on February 26 recommended approval for Celgene K.K.’s multiple myeloma treatment pomalidomide. Pomalidomide, a derivative of thalidomide designated as an orphan...read more